September 30, 2022

There are a lot of major advancements linked to biological medicines, including many pathological conditions such as autoimmune diseases and cancer. Biosimilars, a lower cost alternative to many biological medicines, have boosted patient access to a lot of these modern therapies. This is something that’s likely to boost even further, especially as therapies requiring biosimilars